Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Genetics

Open Access

Instability of the insertional mutation in Cftr TgH(neoim)Hgu cystic fibrosis mouse model

  • Nikoletta Charizopoulou1Email author,
  • Silke Jansen1,
  • Martina Dorsch2,
  • Frauke Stanke1,
  • Julia R Dorin3,
  • Hans-Jürgen Hedrich2 and
  • Burkhard Tümmler1
BMC Genetics20045:6

https://doi.org/10.1186/1471-2156-5-6

Received: 18 February 2004

Accepted: 21 April 2004

Published: 21 April 2004

Abstract

Background

A major boost to the cystic fibrosis disease research was given by the generation of various mouse models using gene targeting in embryonal stem cells. Moreover, the introduction of the same mutation on different inbred strains generating congenic strains facilitated the search for modifier genes. From the original CftrTgH(neoim)HguCF mouse model we have generated using strict brother × sister mating two inbred CftrTgH(neoim)Hgumouse lines (CF/1 and CF/3). Thereafter, the insertional mutation was introgressed from CF/3 into three inbred backgrounds (C57BL/6, BALB/c, DBA/2J) generating congenic animals. In every backcross cycle germline transmission of the insertional mutation was monitored by direct probing the insertion via Southern RFLP. In order to bypass this time consuming procedure we devised an alternative PCR based protocol whereby mouse strains are differentiated at the Cftr locus by Cftr intragenic microsatellite genotypes that are tightly linked to the disrupted locus.

Results

Using this method we were able to identify animals carrying the insertional mutation based upon the differential haplotypic backgrounds of the three inbred strains and the mutant CftrTgH(neoim)Hguat the Cftr locus. Moreover, this method facilitated the identification of the precise vector excision from the disrupted Cftr locus in two out of 57 typed animals. This reversion to wild type status took place without any loss of sequence revealing the instability of insertional mutations during the production of congenic animals.

Conclusions

We present intragenic microsatellite markers as a tool for fast and efficient identification of the introgressed locus of interest in the recipient strain during congenic animal breeding. Moreover, the same genotyping method allowed the identification of a vector excision event, posing questions on the stability of insertional mutations in mice.

Background

Cystic fibrosis (CF) is a common and fatal recessive disease, which is caused by dysfunction of a chloride channel, termed the CF transmembrane conductance regulator (CFTR). Since the isolation of the murine homologue of the human CFTR gene on Chromosome 6 [1] several mouse models have been created. These fall broadly into two different categories; those designed to mimic clinical human mutations such as the F508del [24], G551D [5] and G480C [6], and those with a disrupted Cft r gene resulting in either no or reduced production of CFTR. Although most mouse models share phenotypic characteristics, particularly, the most CF-like severe pathology is observed in the gastrointestinal tract, important variations in phenotype have been observed which may relate to the specific mutation and the genetic background of the targeted strain. Studies using Cftr knockout mice demonstrated differential severity of airway [7] and intestinal [8] disease. Candidate modulators for growth, airway and intestinal disease have been mapped to loci on chromosomes 1, 6, 7, 10 and 13 [9]; 1, 2, 10 and 17 [10]; 3 and 5 [11], respectively.

Dorin et al. [12] established a CF mutant mouse CftrTgH(neoim)Hgu, using an insertional gene targeting vector to disrupt exon 10 of the Cftr gene in 129P2 embryonic stem cells. This targeted mutation was made by insertional mutagenesis using a fragment of DNA containing intron 9 and part of exon 10 (Figure 1). The mutation is slightly "leaky", in that low levels of wild type Cftr mRNA are produced as a result of exon skipping and aberrant splicing [13], but these mutant mice nevertheless displayed the electrophysiological defect in the gastrointestinal and respiratory tract which is characteristic of CF [14]. We have generated two different inbred lines named CF/1- CftrTgH(neoim)Hguand CF/3- CftrTgH(neoim)Hguusing brother-sister mating for more that 26 generations. In order to test whether the genetic background of the CftrTgH(neoim)Hgumouse influences the development of the phenotype, we introgressed the mutation from the CF/3- CftrTgH(neoim)Hguinto three different inbred strains (C57BL/6, BALB/c, DBA/2J) generating B6.129P2(CF/3)- CftrTgH(neoim)Hgu, C.129P2(CF/3)-CftrTgH(neoim)Hgu, D2.129P2(CF/3)-CftrTgH(neoim)Hgucongenic mice. During backcrossing the targeted mutation was determined by Southern RFLP analysis of Xba I/Sal I genomic digests with probe 1.2H (Figure 1) as outlined in the original report [12]. Here we describe an alternative genotyping technique utilising informative Cftr intragenic microsatellite markers in order to follow germline transmission of the mutated Cftr locus in the three inbred backgrounds. The four markers spanning 101 kb of the Cftr gene allowed straight forward differentiation between the two inbred CF strains and the three inbred wild type strains by microsatellite haplotype. Southern and microsatellite mutation genotypes were confirmed in 55 of 57 typed mice. In two cases, however, the insertion mutation status deduced from Southern hybridisation and microsatellite genotypes did not match. Further mapping and sequencing revealed that the 7.3 kb insertion vector had been excised from the Cftr locus. This spontaneous reversion to wild type sheds serious doubts for the stability of insertion mutations in heterozygous mice.
Figure 1

Generation of the Cftr TgH ( neoim ) Hgu mouse model. a) Insertional disruption of the murine Cftr gene and predicted gene structure as described by Dorin et al. (1992). Abbreviations: S, Sal I; H, Hind III; X, Xba I. Map position of the CFneo1 and CFneo2 products is also indicated. b) Genotype analysis of heterozygous cf/+ matings. The probe 1.2H issued in order to identify via Southern hybridisation the congenic mice which carry the insertion. DNAs were digested with Xba I+Sal I and probed with 1.2H. The upper hybridising fragment of 6.6 Kb represents the wild type allele, the lower 5 Kb fragment is diagnostic for the insertional mutation.

Results

From the original CftrTgH(neoim)Hgumutant mouse generated using insertional mutagenesis in the Cftr exon 10 [12] we have established two inbred CF strains CF/1- CftrTgH(neoim)Hguand CF/3- CftrTgH(neoim)Hguby strict brother sister mating. We have generated three inbred congenic strains by backcrossing the targeted mutation to three different inbred backgrounds C57BL/6, DBA/2J and BALB/c. To observe germline transmission of the mutation after each backcross and after the first incross to develop homozygous congenic strains, mice were genotyped using Southern Blot Hybridisation to indicate the transmission of the insertional vector pIV3.5H (Figure 1). Since Southern analysis is cumbersome and time consuming, we devised an alternative protocol for genotyping, whereby animals are differentiated at the Cftr locus by intragenic microsatellite genotypes tightly linked with the intron 9 and exon 10 of Cftr chosen for insertion mutagenesis in the CftrTgH(neoim)Hgumouse mutant.

Allele distribution between the strains. Consistent genotyping

Four of the six tested Cftr intragenic microsatellite markers (D6NC3, D6NC2, D6Mit236 and D6NC5) allowed the discrimination of the three inbred strains (C57BL/6, BALB/c, DBA/2J) from the two inbred CF strains CF/1- CftrTgH(neoim)Hguand CF/3- CftrTgH(neoim)Hgu(Figure 2). The two inbred CF/1-CftrTgH(neoim)Hguand CF/3- CftrTgH(neoim)Hgulines shared the same marker alleles in all four informative microsatellites being distinct from the three inbred strains. (Figure 2). Hence, a mouse homozygous for the disrupted locus can be identified by the genotype: D6NC3:20/20, D6NC2:20/20, D6Mit236: 20/20, D6NC5: 20/20. Accordingly, the representative genotypes of a a) wild type BALB/c animal will be (D6NC3: 16/16, D6NC2: 13/13, D6Mit236: 31/31, D6NC5: 30/30); b) wild type C57BL/6 (D6NC3: 14/14, D6NC2: 15/15, D6Mit236: 35/35, D6NC5: 21/21); c) wild type DBA/2J(D6NC3: 16/16, D6NC2: 13/13, D6Mit236: 44/44, D6NC5: 32/32).
Figure 2

Microsatellite genotyping. a) Localisation of the intragenic polymorphisms on the physical map of the murine Cftr gene. b) Analysis of the four informative intragenic microsatellites by direct blotting electrophoresis. c) Microsatellite alleles were ascertained by arbitary repeat units. The alleles for all four microsatellites which are representative of the two CF inbred lines (CF/1 and CF/3)and hence directly linked with the disease causing allele carrying the insertional vector pIV3.5H in Cftr exon 10 have been given the number 20.

In order to determine whether germline transmission of the mutation can be accurately assessed via the haplotype of the informative intragenic microsatellites linked to the disrupted Cftr locus, we tested all three congenic strains. Fifty-seven animals (C.129P2(CF/3)-CftrTgH(neoim)Hgun = 31, B6.129P2(CF/3)- CftrTgH(neoim)Hgun = 9 and D2.129P2(CF/3)-CftrTgH(neoim)Hgun = 17) selected at random at generation N10F2 and N10F3 from both heterozygous and homozygous CF matings were compared in the 1.2H probe restriction Xba I/Sal I RFLP and marker genotypes of the three informative intragenic Cftr microsatellites (D6NC3 intron1, D6Mit236 intron 9, D6NC5 intron 18) equally distributed along the Cftr gene. Southern RFLP and microsatellite marker genotypes were authenticated for 55 mice. Absence and presence of the insertional mutation in intron 9/exon 10 in homozygous or heterozygous mice could be clearly deduced from the microsatellite genotypes (Figure 2 – Table 1).
Table 1

Expected Southern and microsatellite genotypes for animals backcrossed to the three inbred backgrounds.

 

1,2H

D6NC3

D6Mit236

D6NC5

 

BALB/c

     
 

n/n

16/16

31/31

30/30

Homozygote wt

 

cf/n

16/20

31/20

30/20

Heterozygote mt

 

cf/cf

20/20

20/20

20/20

Homozygote mt

C57BL/6

     
 

n/n

14/14

35/35

21/21

Homozygote wt

 

cf/n

20/14

20/35

20/31

Heterozygote mt

 

cf/cf

20/20

20/20

20/20

Homozygote mt

DBA/2J

     
 

n/n

16/16

44/44

32/32

Homozygote wt

 

cf/n

20/16

20/44

20/32

Heterozygote mt

 

cf/cf

20/20

20/20

20/20

Homozygote mt

Excision of the pIV3.5H vector

In two out of the 57 investigated animals the mutant genotypes as defined by Southern and microsatellite genotypes were discordant (Table 2). In detail, mouse A was classified heterozygous CF by Southern and homozygous CF by the microsatellites and mouse B homozygous wild type by Southern and homozygous CF by the microsatellites. Genotyping via Southern Blot Hybridization indicates and depends upon the existence or absence of the insertional vector pIV3.5H designed to disrupt the Cftr gene in exon 10. Therefore, as a first step we tried to verify the presence or absence of the pIV3.5H vector with a straight forward PCR assay that scans the ends of the heterologous vector sequence (Figure 1). One PCR product scans the junctions between intron 9 and the inserted plasmid sequence, the other PCR product the junction between the neo gene and the endogenous intron 9 encompassing the unique Sal I site. The results of the PCR assays were consistent with the Southern data i.e. for mouse A both insert specific products were present indicating an intact vector on one chromosome, whereas for mouse B both products were absent. This data strongly suggests that the pIV3.5H insertion vector had been excised from the CF/3- CftrTgH(neoim)HguCftr locus at least in mouse B.
Table 2

Genotypes of the animals with an excised vector. Mouse A in one chromosome, Mouse B in both chromosomes.

mouse

1.2H

D6NC3

D6Mit236

D6NC5

A

cf/n

cf/cf (20/20)

cf/cf (20/20)

cf/cf (20/20)

B

n/n

cf/cf (20/20)

cf/cf (20/20)

cf/cf (20/20)

In order to corroborate this suspicion that the vector had been excised in both the heterozygous and homozygous state a long range PCR protocol was established that encompasses the targeted region in intron 9 and exon 10 for both wild type and mutant chromosomes. Four sets of primers were designed (Table 3), one product of 5012 bp corresponding to wild type Cftr allele and three primer sets corresponding to the mutant allele with the inserted sequence (Figure 3). Mouse B was positive only for the 5012 bp product confirming the absence of the pIV3.5H vector on both chromosomes, whereas mouse A was positive for all four products indicative of a CF heterozygous mouse. In mouse B the inserted vector had been excised from both chromosomes, and in mouse A in one chromosome.
Table 3

Primer sequences used for the amplification of the long range products.

Primer name

Primer sequence 5'-3'

Expected size

Allele

Cftr-5012

CCT TCC ATG TAC CCC TCC TCA CTT

5012 bp

Wild type

 

CCC GGC ATA ATC CAA GAA AAT TG

  

Cftr-5198

TGT GGG AAA TCC TGT GCT GAA A

5198 bp

mutant

 

CTT CCG GCT CGT ATG TTG TGT T

  

Cftr-3736

CAC ACA ACA TAC GAG CCG GAA G

3736 bp

mutant

 

TTT ATT GCC GAT CCC CTC AGA A

  

Cftr-3473

CTC GTG CTT TAC GGT ATC GCC

3473 bp

mutant

 

TGC TGT AGT TGG CAA GCT TTG A

  
Figure 3

Long range PCR. a) Map position of the long range PCR product corresponding to the 5012 bp wild type sequence. b) Map position of the three long range products corresponding to the mutant allele. c) Representative agarose gel (1%) indicating the expected PCR products for all four primer sets.

Primer walking

The sequence integrity of the complete homologous targeted region was checked by primer walking. Fifteen sets of primers were designed from Cftr exon 9 to intron 10 (Table 4, Figure 4), and all products of the mutant mice were compared against the BALB/c wild type control. PCR products suspicious for differential migration behaviour on 2.5% agarose compared to those obtained from the wild type BALB/c DNA were sequenced. For all five selected PCR products including NC13 which corresponds to the area in Cftr intron 9 where the vector was introduced via homologous recombination [12] the sequence was found to be 100% wild type Cftr with no insertional vector (pIV3.5H) sequence retention. Small sequence alterations were observed when compared to the AF162137 database C57BL/6 derived sequence, most likely representing SNPs between the mouse strains used for the generation of the CftrTgH(neoim)Hgumouse model (MF/1, 129P2) and the C57BL/6 mouse strain. In summary, since sequencing by primer walking revealed neither any loss of wild type Cftr sequence nor retention of vector sequence, we conclude that in the two mice the pIV3.5H insertion vector had been completely removed (by the base) from the disrupted Cftr locus.
Table 4

Primer sequences used for primer walking spanning the entire region from Cftr exon 9 to Cftr intron 10. Location based on the Genome Database Cftr sequence (AF 162137)

Primer name

Location

Sequence 5'-3'

Product Size

NCEx9I9-A

197720- 197742

TTT GGG GAA TTA CTG GAG AAA G

419 bp

NCEx9I9-B

198138- 198117

AGC TCG CTG ATA GGT TAT CCA

 

NC10-A

198002-198023

CCC CTC CTC ACT TCC ATT AAA

400 bp

NC10-B

198402-198381

TTT AAG GCT CAG GGC TAA TTG

 

NC11-A

198376- 198396

TTC CAC AAT TAG CCC TGA GC

649 bp

NC11-B

199024- 199001

TGA AGG AAA TCA TTA CTG AAG CA

 

NC12-A

199001- 199024

TGC TTC AGT AAT GAT TTC CTT CA

550 bp

NC12-B

199551- 199531

TAT GGA TCC CCA CAG CAA GT

 

NC13-A

199394- 199414

CTC AGG GAT TGT CAC GGT TT

563 bp

NC13-B

199966- 199946

GCT TTG ATC TCT GGG AGC AC

 

NC14-A

199741- 199763

GAT CAC AGG AGC CTA GCA TAG A

550 bp

NC14-B

200290- 200268

TTC ACT TTA CAT CCT GGC TTC A

 

NC15-A

200122- 200142

ACT GGG AGA GGA TGC AAA AA

575 bp

NC15-B

200696- 200676

CCC AGT GTG AGA AGA TGC AC

 

NC16-A

200572- 200592

TGC TCC CAG AAA TCT TCA CC

582 bp

NC16-B

201153- 201133

AGT TGT CAG AAG GGA ACC CA

 

NC17-A

201134- 201154

TGG GTT CCC TTC TGA CAA CT

582 bp

NC17-B

201715- 201695

TTA GGT CCC CGT GCT TAC AC

 

NC19-A

201739- 201759

TAG GTG GAT CCA TAA CCC CA

480 bp

NC19-B

202219- 202199

GGA CAG AGA AGC AGG AGT GG

 

NC20-A

202199- 202219

CCA CTC CTG CTT CTC TGT CC

487 bp

NC20-B

202686- 202666

AAA GAA GAG CGA GCC CCT AC

 

NCI9Ex10-A

202593- 202612

CCA TAG CCC AAG AGC TTT CA

413 bp

NCI9Ex10-B

203007-202987

GTA CCC GGC ATA ATC CAA GA

 

NCEx10I10-A

202986-203006

TTC TTG GAT TAT GCC GGG TA

403 bp

NCEx10I10-B

203387-203367

TTT CCA GTT GGG GGT ACA CT

 

NC21-A

203296- 203316

GGG CTT CAA GGC CTA ATT CT

479 bp

NC21-B

203775- 203755

ATG TGA TCC AGA CTG GCC TA

 

NC22-A

203654- 203674

ATG CAT GGG GTG TGG TAC TT

625 bp

NC22-B

204277- 204255

TCC AAT GAT CTA CCT GTG TCC A

 
Figure 4

Primer walking. Straight lines represent the fragment amplified by each primer set, overlapping sequences are represented by boxes.

Discussion

Genetic analysis of complex human diseases such as cystic fibrosis has been successfully supported by the use of various mouse models. In order to dissect the role of the different induced mutations to the murine Cftr gene used from the genetic background, the genomic section carrying the mutation is transferred by repeated backcross cycles to another defined inbred background (introgressing), creating congenic strains. We have generated three congenic CftrTgH(neoim)Hgustrains by crossing the mutant animals to the three inbred backgrounds BALB/c, C57BL/6, DBA/2J. In each generation germline transmission of the disrupted Cftr locus was monitored using Southern Blot Hybridisation [12]. In order to observe germline transmission of the disrupted Cftr locus we have established an alternative 'high-throughput' genotyping protocol using Cftr intragenic microsatellites, which enabled us to identify animals carrying the insertional mutation based upon the different haplotypic backgrounds of the three inbred strains and the mutant CF/3- CftrTgH(neoim)Hguinbred line at the Cftr locus.

The present study is to the best of our knowledge, the first deliberate search for polymorphic intragenic Cftr markers for the establishment of Cftr haplotypic backgrounds of wild type inbred mouse strains. It has been shown that some of the more common polymorphisms in the human CFTR gene have consequences at the functional level. The presence of an allele at a particular locus can determine the proportion of transcripts from which functional CFTR protein can be translated affecting CFTR maturation and the net chloride transport activity of CFTR-expressing cells [15]. Although it remains to be proven whether intragenic changes can account for phenotypic variability in disease expression among mice with different Cftr background carrying the same mutation, it can not be excluded that they may have a potential effect on the severity of the CF phenotype by several mechanisms.

In our study the determination of the Cftr haplotypic backgroung provided a useful tool for the identification of mutant animals. Using this protocol we have successfully verified the genotype of 55 out of 57 animals bred to the three inbred backgrounds, previously genotyped by Southern blot hybridisation using the 1.2H probe.

Excision

In two separate cases (mouse A and mouse B) the Southern insertional mutation genotype could not be verified with the three intragenic microsatellites. A heterozygous mouse A and a homozygous wild type mouse B, as indicated via Southern blot hybridisation were homozygous for the intragenic microsatellite genotype linked to the disrupted Cftr locus (CF/3- CftrTgH(neoim)Hgubackground). Further investigation on these two mice (see Results section) revealed that the outcome of both genotyping methods was correct, supporting the hypothesis of the event of pIV3.5H insertional vector being excised from the mutated Cftr locus, on both chromosomes in mouse B and in one chromosome in mouse A. Primer walking revealed that the 7.3 kb vector has been excised precisely from the mutated Cftr locus without causing any sequence alteration in the Cftr gene. Both mouse A and mouse B are littermates of the same two parental animals heterozygous for the mutation as indicated by Southern blot and Cftr intragenic microsatellite genotyping. Further investigation on the remaining offspring (n = 7) (Table 5) of the same litter from these two parental animals revealed that three further animals had inconsistent genotyping with two animals (C and D) resembling littermate A and mouse E resembling littermate B, whereas four animals (F, G, H, I) were homozygous CF. The above supports the hypothesis that the excision event had occurred during gametogenesis in both the male and the female parental germlines.
Table 5

Mouse A and B littermate genotypes.

mouse

1.2H

D6NC3

D6Mit236

D6NC5

C

cf/n

cf/cf (20/20)

cf/cf (20/20)

cf/cf (20/20)

D

cf/n

cf/cf (20/20)

cf/cf (20/20)

cf/cf (20/20)

E

n/n

cf/cf (20/20)

cf/cf (20/20)

cf/cf (20/20)

F

cf/cf

cf/cf (20/20)

cf/cf (20/20)

cf/cf (20/20)

G

cf/cf

cf/cf (20/20)

cf/cf (20/20)

cf/cf (20/20)

H

cf/cf

cf/cf (20/20)

cf/cf (20/20)

cf/cf (20/20)

I

cf/cf

cf/cf (20/20)

cf/cf (20/20)

cf/cf (20/20)

The mechanism responsible for this excision repair event must be independent from the mismatch repair (MMR) and nucleotide exchange repair (NER) pathways, since the size of the vector overexceeds the maximum of mismatched nucleotides they can efficiently repair [1618]. The mechanism involved in the excision of the vector and the subsequent restoration of the mutated Cftr locus to wildtype can not be gene conversion as seen in other organisms [19, 20], because the genetic background is conserved. If the mechanism involved large loop repair by incorporating the vector in a heteroduplex there must be a novel mechanism, which is independent of gene conversion-restoration events.

O type sequence insertion vectors [21] such as the pIV3.5H, contain an uninterrupted stretch of target- homology with exonic sequence that results in duplication of a large stretch of sequence flanking the heterologous sequence of the plasmid resembling transposable elements, flanked by large direct repeats. Reports [22] on precise excision events of transposable elements without leaving a footprint involve an alternative mechanism of repair rather than gene conversion which is dependent on length of the repeat flanking the element. It is therefore highly likely that a similar mechanism is responsible for the precise excision of the pIV3.5H insertion vector.

This is the first report where an O type vector used in order to generate insertion mutagenesis in the mouse, has been excised. Such events probably remained unnoticed because most of the methods used in order to identify animals which carry the targeted locus base their detection almost exclusively on the presence or absence of the inserted sequence, without taking into consideration the genetic background of the mouse strain adjacent to the insertion, therefore an excision event would not be easily identified. Unlike Southern hybridisation the genotyping protocol that we propose in this study does not indicate the presence of the insertion vector directly based on the presence of its sequence in the disrupted locus, but manages to discriminate insertional mutant animals from the haplotypes associated with the disrupted locus in the Cftr gene. In our study the haplotypes obtained from the three informative intragenic Cftr microsatellites were differential to the haplotypes associated with the insertional mutant mouse, allowing identification of excision events.

Conclusion

Microsatellite markers spanning the mouse genome have been used for the enhancement of congenic breeding, reducing the time to 18–24 months (speed congenics) from an initial 2.5–3 year period [23, 24]. Here we describe the use of Cftr intagenic markers which allowed fast and efficient identification of the differential locus during backcrossing. Moreover, this method provided a useful tool whereby unexpected events such as vector excision from the disrupted Cftr locus have been revealed posing questions for the stability of insertional mutants generated by this strategy. Furthermore, given our observations that different haplotypic backgrounds were found between the inbred strains raises questions on whether alleles at polymorphic loci can affect cftr at the transcript and/or protein level and whether it would be beneficial to study Cftr induced mutations on the respective haplotypic background of the individual strains.

Methods

Experimental animals

All experiments were approved by the local Institutional Animal Care and Research Advisory Committee as well as by the local government. CftrTgH(neoim)Hgumice were bred under specified pathogen-free conditions in the isolator unit of the Central Laboratory Animal Facility of the Hannover Medical School. Mice were kept in a flexible film isolator. The temperature within the isolator was maintained at 20–24°C with 40–50% relative humidity. Animals were fed an irradiated (50 kGy) standard chow (Altromin 1314) and autoclaved water (134°C for 50 min) ad libitum.

Generation of inbred CftrTgH(neoim)Hgumutant mice

For the establishment of the inbred CF/1-CftrTgH(neoim)Hguand CF/3- CftrTgH(neoim)Hgupopulation, one pair with divergent genetic background (generation F4) of one homozygous male and one homozygous female was obtained from the MRC Human Genetics Unit, Edinburgh. Two separate litters were obtained and two animals of each litter became the starting population for the establishment of the two individual inbred CftrTgH(neoim)Hgulines CF/1- CftrTgH(neoim)Hguand CF/3- CftrTgH(neoim)Hguwhich were generated by brother-sister mating for now more than 26 generations.

Generation of congenic CftrTgH(neoim)Hgumutant mice

CF/3- CftrTgH(neoim)Hgumice served as donors for the development of the three congenic strains C57BL/6, BALB/c and DBA/2J, with selection for CftrTgH(neoim)Hgufor 10 generations. Genotyping of the insertion mutation was conducted by Southern analysis of Xba I/Sal I restricted genomic DNA from spleen [12].

DNA purification

High molecular weight DNA was isolated from 0.15 g spleen tissue, either fresh or thawed on ice after storage at -20°C based on the protocol by Gross-Bellard et al. [25].

Southern blot genotyping

Heterozygous and homozygous CftrTgH(neoim)Hguanimals were identified in each backcross generation via Southern Blot Hybridization of Xba I/Sal I genomic digests, using the 1.2H probe located in the Cftr intron 10, after double digestion with Xba I-Sal I (Figure 1). There are no Sal I sites in this region of the Cftr gene, but the targeting vector pIV3.5H carries a unique Sal I site immediately 3' to the neo gene. Animals carrying the mutation were identified by the novel 5 kb Xba I-Sal I fragment hybridizing to 1.2H.

Microsatellite selection

The sequence available in the Genome Database (AF162137) was used for manual selection of dinucleotide repeat units spanning the murine Cftr gene. Five microsatellite markers were identified in Cftr intron 1 (D6NC3), intron 2 (D6NC4), intron 8 (D6NC2), intron 10 (D6NC1) and intron 18 (D6NC5). Flanking primers designed with the oligonucleotide designing program Primer 3 http://frodo.wi.mit.edu are listed in Table 6.
Table 6

Primer sequences used for the amplification of the intragenic Cftr microsatellites. The forward primer is 5'biotinylated.

Primer name

Primer sequence 5'-3'

D6NC1-A

BIOTIN-TGC TTG AGC TAT CCA TTC TGA

D6NC1-B

TAC CCA ATG TTG CCA TCT GA

D6NC2-A

BIOTIN-TTG GAA GTG AGG ATT GCC TT

D6NC2-B

TGC CTC AGT CTC ATA TTA TTG C

D6NC3-A

BIOTIN-TCT CAG CCT GTC TTC CTC TCA

D6NC3-B

TCC TCC CAA AAC AGC TTC AC

D6NC4-A

BIOTIN-GAG TTG GAG AGG CTG TTT GG

D6NC4-B

TGT GCC AGG ACA CTG TGA CT

D6NC5-A

BIOTIN-TTC AAA TGA CCA AAA TCC CC

D6NC5-B

TGG CAA ATT TTC AAC AAC AAA

Genotyping of microsatellites

Microsatellite markers were genotyped in 96 well plates purchased from Greiner, Frickenhausen, pre-coated with 50 ng DNA per well in a Hybaid Thermocycler (Hybaid, Teddington) with a heated lid. One of the two primers per microsatellite was 5'-terminal biotinylated. PCR was performed in a total volume of 30 μl, without oil overlay, using InViTaq polymerase (InViTek, Berlin). After PCR an 8 μl aliquot was transferred to a multiwell plate and allowed to dry overnight at 37°C, dissolved in 10 μl loading buffer (0.2% w/v xylenecyanol and bromphenolblue in formamide) and denatured for 5 min at 95°C. The PCR products were separated by direct blotting electrophoresis (GATC 1500, MWG Biotech, Ebersberg, Germany) on a denaturing acrylamide gel (4% acrylamide/N,N'-methylenebisacrylamide 29:1 containing 6 M urea in 0.9 M Tris-0.9 M boric acid-0.02 M EDTA buffer) and simultaneously transferred to a Hybond N+membrane (Amersham). Signals were visualised by blocking the membrane in 1.5%(w/v) of blocking reagent in Buffer 1 (100 mM Tris-HCl, 150 mM NaCl, pH 7.5), followed by incubation in diluted solution of anti-biotin alkaline phosphatase conjugate in Buffer 1. The membrane was further washed three times with 1% Triton X-100 in Buffer 1 and equilibrated for 15 min in assay buffer (100 mM Tris-HCl, 100 mM NaCl, 50 mM MgCl2, pH 9.5). The membrane was covered for 5 min with reaction buffer containing 10%(v/v) Sapphire II (Tropix) and 60 μl CDPstar (Tropix)in 50 ml assay buffer, followed by rinsing with a solution containing 1% v/v Sapphire II and 6 μl CDPstar in 50 ml assay buffer. Signals were exposed to Kodak XA-R films and the exposition time varied from 10 min to 45 min. Evaluation of results was performed as described by Mekus et al. [26].

Long-range PCR

150 ng of DNA template was each amplified in 12 different premixes using the Failsafe ™ PCR System (EPICENTRE Technologies, WI USA). PCR products were amplified using primers described in Table 3 separated by 1% agarose gel electrophoresis and visualised under UV illumination, the optimal reaction mixture was thereafter chosen for further amplifications (Figure 3).

Neo PCR

Cftr intron 9-pIV3.5H vector and neo -Cftr intron 9 spanning primers, (Table 7) were amplified using PCR of 50 ng DNA template in a total volume of 30 μl with InViTaq polymerase (InViTek, Berlin) in 96 well plates. Full-length and Sal I restricted PCR products were separated by 2.5% agarose gel electrophoresis.
Table 7

Primer sequences used for the amplification of the Cftr intron 9-pMC1 vector plasmid sequence (CFneo2) and the neomycin-Cftr intron 9 (CFneo1) products.

Primer name

Primer sequence 5'-3'

Expected size

CFneo 1-A

CGT TGG CTA CCC GTG ATA TT

332 bp

CFneo 1-B

CTT CCA CAA GGC TTC CTG AG

 

CFneo2-A

CCT GAT GTT GAT TTT GGG AGA

253 bp

CFneo2-B

ATT AAT GCA GCT GGC ACG AC

 

Excision scanning by primer walking

Based on the Genome Database Cftr sequence (AF162137) 15 overlapping pairs (Table 4) of primers spanning the entire region from exon 9 to intron 10 of the murine Cftr gene were designed, using the Primer 3 oligo design program http://frodo.wi.mit.edu. PCR reactions were performed on DNA with inconsistent Southern and microsatellite insertional mutation genotypes and controls in 96 well plates precoated with 50 ng of DNA template using InViTaq polymerase (InViTek, Berlin). Full length products were separated on 2.5% agarose gels and visualised under UV illumination.

Sequencing

Following PCR amplification the chosen PCR products were sequenced by Qiagen GmbH.

Declarations

Acknowledgments

We thank Petra Adomat and Harry Dettmering for excellent animal care and Margit Ritzka for experimental advice. We thank David J. Porteous for thorough discussions during the initial stage of the project. Financial support by the Deutsche Forschungsgemeinschaft to H.-J. H. and B.T. (HE 1058/3-2) is gratefully acknowledged.

Authors’ Affiliations

(1)
Klinische Forschergruppe, OE 6710, Medizinische Hochschule Hannover
(2)
Zentrales Tierlaboratorium, OE 8600, Medizinische Hochschule Hannover
(3)
MRC Human Genetics Unit, Western General Hospital

References

  1. Tata F, Stanier P, Wicking C, Halford S, Kruyer H, Lench NJ, Scambler PJ, Hansen C, Braman JC, Williamson R, Wainwright BJ: Cloning the mouse homolog of the human cystic fibrosis transmembrane conductance regulator gene. Genomics. 1991, 10: 301-307.View ArticlePubMedGoogle Scholar
  2. Colledge WH, Abella BS, Southert KW, Ratcliff R, Jiang C, Cheng SH, MacVinish LJ, Anderson JR, Cuthbert AW, Evans MJ: Generation and characterisation of a DeltaF508 cystic fibrosis mouse model. Nat Genet. 1995, 10: 445-452.View ArticlePubMedGoogle Scholar
  3. van Doorninck JH, French PJ, Verbeek E, Peters RHPC, Monrreau H, Bijman J, Scholte BJ: A mouse model for the cystic fibrosis deltaF508 mutation. EMBO J. 1995, 14 (18): 4403-4411.PubMed CentralPubMedGoogle Scholar
  4. Zeiher BG, Eichwald E, Zabner J, Smith JJ, Puga AP, McGray PB, Capecchi MR, Welsh MJ, Thomas KR: A mouse model for the deltaF508 allele of cystic fibrosis. J Clin Invest. 1995, 96: 2051-2064.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Delaney SJ, Alton EWFW, Smith SN, Lunn DP, Farley R, Lovelock PK, Thomson SA, Hume DA, Lamp D, Porteous DJ, Dorin JR, Wainwright BJ: Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations. EMBO J. 1996, 15: 955-963.PubMed CentralPubMedGoogle Scholar
  6. Dickinson P, Smith SN, Webb S, Kilanowski FM, Campbell IJ, Taylor MS, Porteous DJ, Willemsen R, de Jonge HR, Farley R, Alton EWFW, Dorin JR: The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectrics. Human Molecular Genetics. 2002, 11 (3): 243-51. 10.1093/hmg/11.3.243.View ArticlePubMedGoogle Scholar
  7. Kent G, Iles R, Bear CE, Huan LJ, Griesenbach U, McKerlie C, Frndova H, Ackerley C, Gosselin D, Radzioch D, O'Brodovich H, Tsui LC, Buchwald M, Tanswell AK: Lung disease in mice with cystic fibrosis. J Clin Invest. 1997, 100: 3060-3069.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, Moore A, Fostner J, Durie P, Nadeau J, Bear C, Tsui L-C: Modulation of disease severity in cystic fibrosis transmembranen regulator deficient mice by a secondary genetic factor. Nature Genetics. 1996, 12: 280-287.View ArticlePubMedGoogle Scholar
  9. Haston CK, Corey M, Tsui L-C: Mapping of genetic factors influencing the weight of cystic fibrosis knockout mice. Mammalian Genome. 2002, 13: 614-618. 10.1007/s00335-002-2195-2.View ArticlePubMedGoogle Scholar
  10. Haston CK, McKerlie C, Newbigging S, Corey M, Rozmahel R, Tsui L-C: Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice. Mammalian Genome. 2002, 13: 605-613. 10.1007/s00335-002-2190-7.View ArticlePubMedGoogle Scholar
  11. Haston CK, Tsui L-C: Loci of intestinal distress in cystic fibrosis knockout mice. Physiol Genomics. 2002, 12: 79-84.View ArticleGoogle Scholar
  12. Dorin JR, Dickinson P, Alton EWFW, Smith N, Geddes DM, Stevenson BJ, Kimber WL, Fleming S, Clarke AR, Hooper ML., Anderson L, Beddington RSP, Porteous DJ: Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature. 1992, 359: 211-215. 10.1038/359211a0.View ArticlePubMedGoogle Scholar
  13. Dorin JR, Stevenson BJ, Fleming S, Alton EWFW, Dickinson P, Porteous DJ: Long term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression. Mammalian Genome. 1994, 5: 465-472.View ArticlePubMedGoogle Scholar
  14. Smith SN, Steel DM, Middleton PG, Munkonge FM, Geddes DM, Caplen NJ, Porteous DJ, Dorin JR, Alton EWFW: Bioelectric characteristics of exon 10 insertional cystic fibrosis mouse: comparison with humans. Am J Physiol. 1995, 268: C297-C307.PubMedGoogle Scholar
  15. Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberhen A, Jorissen M, Droogmans G, Reynaert I, Goosens M, Nilius B, Cassiman J-J: Polyvariant Mutant Cystic Fibrosis Transmembrane Conductance Regulator Genes. J Clin Invest. 1998, 101 (2): 487-496.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Corrette-Bennett SE, Mohlman NL, Rosado Z, Miret JJ, Hess PM, Parker BO, Lahue RS: Efficient repair of large DNA loops in Saccharomyces cerevisiae. Nucleic Acids Research. 2001, 29 (20): 4134-4143. 10.1093/nar/29.20.4134.PubMed CentralView ArticlePubMedGoogle Scholar
  17. Fang W-h, Wang B-J, Wang C-H, Lee S-J, Chang Y-T, Chuang Y-K, Lee C-N: DNA Loop repair by E coli Cell extracts. The Journal of Biological Chemistry. 2003, 278 (25): 22446-22452. 10.1074/jbc.M302585200.View ArticlePubMedGoogle Scholar
  18. McCulloch SD, Gu L, Li G-M: Bi-directional processing of DNA loops by mismatch repair-dependent and -independent pathways in human cells. The Journal of Biological Chemistry. 2003, 278 (6): 3891-3896. 10.1074/jbc.M210687200.View ArticlePubMedGoogle Scholar
  19. Kearney HM, Kirkpatrick DT, Gerton JL, Petes TD: Meiotic recombination involving heterozygous large insertions in S cerevisiae: Formation and repair of large unpaired loops. Genetics. 2001, 158: 1457-1476.PubMed CentralPubMedGoogle Scholar
  20. Clikeman JA, Wheeler SL, Nickoloff JA: Efficient incorporation of large (>2 kb) heterologies into heteroduplex DNA:Pms1/Msh2-dependent and -independent large loop mismatch repair in S.cerevisiae. Genetics. 2001, 157: 1481-1491.PubMed CentralPubMedGoogle Scholar
  21. Dickinson P, Kimber WL, Kilanowski FM, Stevenson BJ, Porteous DJ, Dorin JR: High frequency gene targeting using insertional vectors. Human Molecular Genetics. 1993, 2 (8): 1299-1302.View ArticlePubMedGoogle Scholar
  22. Scott L, LaFoe D, Weil CL: Adjacent sequences influence DNA repair accompanying transposon excision in maize. Genetics. 1996, 142: 237-246.PubMed CentralPubMedGoogle Scholar
  23. Wakeland E, Morel L, Achey K, Yui M, Longmate J: Speed congenics: a classic teqnique in the fast lane (relatively speaking). Immunol Today. 1997, 18 (10): 472-7. 10.1016/S0167-5699(97)01126-2.View ArticlePubMedGoogle Scholar
  24. Visscher PM: Speed congenics: accelerate genome recovery using genetic markers. Genet Res. 1999, 74 (1): 81-85. 10.1017/S0016672399003857.View ArticlePubMedGoogle Scholar
  25. Gross-Bellard M, Dudet P, Chambon P: Isolation of high molecular weight DNA from mammalian cells. Eur J Biochem. 1973, 36: 32-38.View ArticlePubMedGoogle Scholar
  26. Mekus F, Dörk T, Deufel T, Tümmler B: Analysis of microsatellites by direct blotting electrophoresis and chemiluminescence detection. Electrophoresis. 1995, 16: 1886-1888.View ArticlePubMedGoogle Scholar

Copyright

© Charizopoulou et al; licensee BioMed Central Ltd. 2004

This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

Advertisement